Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes

被引:15
作者
Kedderis, GL
Elmore, AR
Crecelius, EA
Yager, JW
Goldsworthy, TL
机构
[1] Integrated Syst Lab Inc, Res Triangle Pk, NC 27709 USA
[2] Battelle Marine Sci Lab, Sequim, WA 98382 USA
[3] Elect Power Res Inst, Palo Alto, CA 94303 USA
关键词
arsenic methylation kinetics; B6C3F1 mouse hepatocytes; monomethylarsenic; substrate inhibition;
D O I
10.1016/j.cbi.2006.04.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The toxic and carcinogenic effects of arsenic may be mediated by both inorganic and methylated arsenic species. The methylation of arsenic(III) is thought to take place via sequential oxidative methylation and reduction steps to form monomethylarsenic (MMA) and dimethylarsenic (DMA) species, but recent evidence indicates that glutathione complexes of arsenic(III) can be methylated without oxidation. The kinetics of arsenic methylation were determined in freshly isolated hepatocytes from male B6C3F1 mice. Hepatocytes (> 90% viability) were isolated by collagenase perfusion and suspended in Williams' Medium E with various concentrations of arsenic(III) (sodium m-arsenite). Aliquots of the lysed cell suspension were analyzed for arsenic species by hydride generation-atomic absorption spectrometry. The formation of MMA(III) from sodium arsenite (1 mu M) was linear with respect to time for > 90 min. DMA(III) formation did not become significant until 60 min. MMA(V) and DMA(V) were not consistently observed in the incubations. These results suggest that the glutathione complex mechanism of methylation plays an important role in arsenic biotransformation in mouse hepatocytes. Metabolism of arsenic(V) was not observed in mouse hepatocytes, consistent with inhibition of arsenic(V) active cellular uptake by phosphate in the medium. The formation of MMA(III) increased with increasing arsenic"' concentrations up to approximately 2 mu M and declined thereafter. The concentration dependence is consistent with a saturable methylation reaction accompanied by uncompetitive substrate inhibition of the reaction by arsenic(III). Kinetic analysis of the data suggested an apparent Km of approximately 3.6 mu M arsenic(III), an apparent V-max of approximately 38.9 mu g MMA(III) formed/L/h/million cells, and an apparent K-I of approximately 1.3 mu M arsenic"'. The results of this study can be used in the physiologically based pharmacokinetic model for arsenic disposition in mice to predict the concentration of MMA(III) in liver and other tissues. (c) 2006 Published by Elsevier Ireland Ltd.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 52 条
[1]  
[Anonymous], 1997, ARSENIC EXPOSURE HLT
[2]   Arsenic toxicology: Five questions [J].
Aposhian, HV ;
Aposhian, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (01) :1-15
[3]   A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species [J].
Aposhian, HV ;
Zakharyan, RA ;
Avram, MD ;
Sampayo-Reyes, A ;
Wollenberg, ML .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (03) :327-335
[4]   CELLULAR UPTAKE AND METABOLIC REDUCTION OF PENTAVALENT TO TRIVALENT ARSENIC AS DETERMINANTS OF CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION [J].
BERTOLERO, F ;
POZZI, G ;
SABBIONI, E ;
SAFFIOTTI, U .
CARCINOGENESIS, 1987, 8 (06) :803-808
[5]  
Cleland W. W., 1970, ENZYMES, P1
[6]   In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver [J].
Corrales, FJ ;
Ruiz, F ;
Mato, JM .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :887-894
[7]   ACTIVITIES OF SEVERAL PHASE-I AND PHASE-II XENOBIOTIC BIOTRANSFORMATION ENZYMES IN CULTURED-HEPATOCYTES FROM MALE AND FEMALE RATS [J].
CROCI, T ;
WILLIAMS, GM .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (17) :3029-3035
[8]   Dose-dependent biotransformation of arsenite in rats -: not S-adenosylmethionine depletion impairs arsenic methylation at high dose [J].
Csanaky, I ;
Németi, B ;
Gregus, Z .
TOXICOLOGY, 2003, 183 (1-3) :77-91
[9]   Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats [J].
Csanaky, I ;
Gregus, Z .
TOXICOLOGICAL SCIENCES, 2001, 63 (01) :29-36
[10]   Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes [J].
Drobná, Z ;
Waters, SB ;
Walton, FS ;
LeCluyse, EL ;
Thomas, DJ ;
Styblo, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 201 (02) :166-177